| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2008, p. 2106-2108, Vol. 46, No. 6
0095-1137/08/$08.00+0 doi:10.1128/JCM.00345-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Laboratoire Alphabio, Hôpital Ambroise Paré, Marseille, France,1 Département d'Hépato-Gastroentérologie, Hôpital Saint-Joseph, Marseille, France,2 Département d'Hépato-Gastroentérologie, Institut Arnault Tzanck, Saint-Laurent du Var, France,3 Université Pierre et Marie Curie-Paris 6, CNRS, UMR 7087-AP-HP, Hôpital Pitié-Salpêtrière, Service de Médecine Interne, Paris, France,4 Département Biostatistiques, CDL Pharma, Marseille, France5
Received 19 February 2008/ Returned for modification 2 April 2008/ Accepted 18 April 2008
Occult hepatitis C infection is regarded as a new entity that should be considered when diagnosing patients with a liver disease of unknown origin. Using an ultrasensitive real-time PCR assay, we demonstrated that occult hepatitis C virus (HCV) infection cannot be found in peripheral blood mononuclear cells of patients with cryptogenic liver diseases, HCV-associated systemic vasculitis, or connective tissue diseases. The significance of such occult infection must be elucidated.
Published ahead of print on 30 April 2008.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|